Clinical Trial Update: Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated pemetrexed as first-line therapy for advanced or metastatic breast cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma of the Breast

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Breast Neoplasms, Male | Phase 2 | Status: COMPLETED | Results posted: 2009-06-01